Product Information
SUMATRIPTAN-NAPROXEN 85-500 MG is a generic product labeled by NorthStar Rx LLC, priced at $10.4634 per EA under NDC 16714089101. Its NADAC has been published 369 times since Sep 11, 2019.
FDA first approved this application on Jul 20, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500; 85 mg/1; mg/1
Manufacturer
NorthStar Rx LLCNDC
16714089101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA202803FDA Approved
7/20/2018
TE Code
AB
On Market Since
11/27/2018
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has been published 369 times since Sep 11, 2019, and over the history we have for it it has declined 76.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.4634 per EA |
|---|---|
| All-time high | $54.0163 (Sep 16, 2020) |
| All-time low | $10.4634 (Sep 23, 2026) |
| 52-week high | $19.8987 |
| 52-week low | $10.4634 |
| Median price | $19.5118 |
| Average price | $24.1533 |
| Largest weekly change | +47.6% (May 18, 2022) |
| Weeks tracked | 369 |
| Tracking since | Sep 11, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sumatriptan and Naproxen Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN-NAPROXEN 85-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN-NAPROXEN 85-500 MG, manufactured by NorthStar Rx LLC, is $10.4634 per EA (NDC 16714089101), effective Sep 30, 2026.
How has the price of SUMATRIPTAN-NAPROXEN 85-500 MG changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has declined 76.4%. It has been tracked across 369 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN-NAPROXEN 85-500 MG?
Since Sep 11, 2019, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has ranged from a low of $10.4634 (Sep 23, 2026) to a high of $54.0163 (Sep 16, 2020), with a median of $19.5118 per EA.
Are there cheaper alternatives to SUMATRIPTAN-NAPROXEN 85-500 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUMATRIPTAN-NAPROXEN 85-500 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures SUMATRIPTAN-NAPROXEN 85-500 MG?
SUMATRIPTAN-NAPROXEN 85-500 MG (NDC 16714089101) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.